Annual report pursuant to Section 13 and 15(d)

12. SEGMENTS (Tables)

v3.19.1
12. SEGMENTS (Tables)
12 Months Ended
Dec. 31, 2018
Segment Reporting [Abstract]  
Summarized segment financial information
Year Ended December 31, 2018
    ADMA BioManufacturing   Plasma Collection Centers   Corporate   Consolidated
                 
Revenues   $ 6,797,548     $ 10,044,908     $ 142,834     $ 16,985,290  
                                 
Cost of product revenue     35,485,273       6,709,362       —         42,194,635  
                                 
Gross (loss) profit     (28,687,725 )     3,335,546       142,834       (25,209,345 )
                                 
Loss from operations     (45,633,715 )     (4,470,073 )     (10,185,156 )     (60,288,944 )
                                 
Interest and other expense, net     (1,077,624 )     (967 )     (4,375,910 )     (5,454,501 )
                                 
Net loss     (46,711,339 )     (4,471,040 )     (14,561,066 )     (65,743,445 )
                                 
Capital expenditures     1,580,684       514,916       —         2,095,600  
                                 
Depreciation and amortization expense     2,608,776       814,768       22,854       3,446,398  
                                 
Total assets     57,818,051       5,443,032       25,615,438       88,876,521  

 

Year Ended December 31, 2017
    ADMA BioManufacturing   Plasma Collection Centers   Corporate   Consolidated
                 
Revenues   $ 10,980,987     $ 11,636,739     $ 142,834     $ 22,760,560  
                                 
Cost of product revenue     21,862,140       7,302,181       —         29,164,321  
                                 
Gross (loss) profit     (10,881,153 )     4,334,558       142,834       (6,403,761 )
                                 
Loss from operations     (19,801,455 )     (2,169,192 )     (17,339,349 )     (39,309,996 )
                                 
Interest and other expense, net     (537,235 )     (6,885 )     (3,904,859 )     (4,448,979 )
                                 
Net loss     (20,338,690 )     (2,176,077 )     (21,244,208 )     (43,758,975 )
                                 
Capital expenditures     747,402       1,913,663       15,263       2,676,328  
                                 
Depreciation and amortization expense     2,204,772       436,687       50,842       2,692,301  
                                 
Total assets     54,004,696       3,933,673       50,080,464       108,018,833